Kashiv BioSciences LLC

Kashiv BioSciences, LLC is a fully integrated biosciences company headquartered in Bridgewater, New Jersey with locations in Piscataway, NJ, Chicago IL, and Ahmedabad, India. Kashiv BioSciences’ broad business offering includes drug delivery platforms incorporating delayed release technology and gastric retention systems that improve the efficacy and safety of known drugs, a 505(b)(2) pipeline of development products targeting unmet clinical needs, biosimilars and prodrugs. Additionally, as part of a development collaboration Kashiv BioSciences has approved generic products and products in advanced stages of development, including several complex generic products. Kashiv BioSciences’ medications will improve the lives of patients suffering from cancer as well as neuromuscular, movement and endocrine disorders, among other debilitating conditions, both in the U.S. and globally. The combined breadth of expertise in small and large molecules, peptides, proteins and monoclonal antibodies enables Kashiv BioSciences to develop products with meaningful clinical differentiation and a compelling value proposition for patients, physicians and payers.

网站

https://www.kashivpharma.com/

Kashiv BioSciences LLC的外部链接

所属行业

制药业

规模

201-500 人

总部

Bridgewater，New Jersey

类型

私人持股

领域

Abuse Deterrent Overdose Protection Technology (ADOPT?)、BIOMAXX?、Enhanced Absorption Controlled Release (ENCORE?)、Fast Acting Sublingual Technology (FAST?)和Long-Acting Depot Injections (LOAD?)